VitalCare Signs LOI For Diabetes Treatment Center In Utah
Center Will Provide iCAT Therapy for Type 1 and Type 2 Diabetics
CARSON CITY, Nev. (Business Wire EON) April 28, 2008 --
VitalCare Diabetes Treatment Centers, Inc. (Pink Sheets:VDTI) a Nevada
corporation, today announced they have signed a letter of intent to
establish a joint-venture relationship with South Valley Inpulse Center,
LLC, an existing Diabetes Treatment Center in Draper, Utah. The center
will be administering the FDA approved iCAT treatment for Type 1 and
Type 2 diabetes patients.
Jimmy McDougald, CEO, stated, “This is the
part of our Mid-West launch and we are excited to be offering iCAT
therapy to diabetics in this region. We see this as an opportunity to
work with an established team of healthcare professionals.”
Diana Harrison, Managing Partner of South Valley Inpulse Center, said, “We
are excited about this opportunity to work with VitalCare to expand our
program, giving more people access to this treatment and the hope in a
better quality of life.”
About VitalCare Diabetes Treatment Centers, Inc.
VitalCare Diabetes Treatment Centers, Inc. is a company specializing in
providing Administrative, Marketing, Business Development, Strategic
Planning, Clinical Oversight and Clinical Management Services to the
Diabetes Healthcare Sector, with an emphasis in bringing “Cutting
Edge” medical devices and healthcare services
direct to consumers, focusing on an emerging FDA approved, US and
European Patented technology and treatment intervention for treating
Type 1 and Type 2 Diabetes known as “Intracellular
Activation Therapy (iCAT)”.
Safe Harbor Statement: Forward-looking statements in this release with
respect to VitalCare Diabetes Treatment Centers, Inc.’s
business, financial condition and results of operations, as well as
matters of timing and the prospective terms of the transaction described
are subject to risks and uncertainties that could cause actual results
to differ materially from those expressed in the forward- looking
statements, including, but not limited to, certain delays beyond
VitalCare Diabetes Treatment Centers, Inc.’s
control with respect to market acceptance of their technology and/or
products, whether financing will be available, the effect of the
application of acquisition accounting policies as well as certain other
risk factors which are and may be detailed from time to time in VitalCare’s
filings with the Securities and Exchange Commission.
Post Comment:
Trackback URL: http://eon.businesswire.com/pingpr.php/SW5zZS1Db3VwLUNvdXAtSG9yci1GYWx1LVplcm8=
Bookmark -
Del.icio.us |
Digg |
Furl It |
Spurl |
RawSugar |
Simpy |
Shadows |
Blink It |
My Web
|
